The product poses a threat to consumers because sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke
doi:10.1016/j.bpc.2016.12.004 Ratan ZA, Haidere MF, Hong YH, et al
Micronutrients Assessment, requirements, deficiencies, and interventions
Artificial sweeteners induce glucose intolerance by altering the gut microbiota
Semaglutide, tirzepatide, and liraglutide are FDA-approved GLP-1 peptides that are clinically safe and effective for diabetes and weight management
As a family medicine practice, we know that each patients health journey is unique